Minimally Invasive Glaucoma Surgery (MIGS): an updated literature review

ABSTRACT Glaucoma is considered the biggest cause of irreversible blindness in the world and the increase in intraocular pressure is its main risk factor. Usually, the initial therapy for glaucoma consists of reducing IOP through the instillation of topical hypotensive drugs, with antiglaucoma surgeries being normally reserved for cases in which disease control is not clinically achieved. Classically, the surgical treatment of glaucoma is performed using filtering procedures: trabeculectomy; non-penetrating sclerotomy and glaucoma drainage devices. The acronym MIGS (Minimally Invasive Glaucoma Surgery) corresponds to a group of minimally invasive surgical procedures that provide a safer and more predictable pressure reduction when compared to conventional antiglaucoma surgical techniques.

摘要：青光眼被认为是全球范围内最主要的不可逆性致盲病因，眼内压升高是其主要危险因素。通常，青光眼的初始治疗方案为通过局部滴用降眼压药物以降低眼内压，而抗青光眼手术通常仅用于临床无法有效控制病情的病例。经典的青光眼外科治疗采用滤过性手术，具体包括小梁切除术、非穿透性巩膜切开术以及青光眼引流装置。缩写MIGS（Minimally Invasive Glaucoma Surgery，微创青光眼手术）指代一类微创手术技术，相较于传统抗青光眼手术技术，该类术式可实现更安全且可预测的眼压降低效果。